Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax RateWages, Salaries and Other
Others
Ratios

Ptc Therapeutics (PTCT) Tax Provisions (2016 - 2025)

Ptc Therapeutics (PTCT) has 11 years of Tax Provisions data on record, last reported at $63.3 million in Q1 2025.

  • For Q1 2025, Tax Provisions rose 819.56% year-over-year to $63.3 million; the TTM value through Mar 2025 reached $56.6 million, up 184.93%, while the annual FY2025 figure was $5.9 million, 3235.23% up from the prior year.
  • Tax Provisions reached $63.3 million in Q1 2025 per PTCT's latest filing, up from -$28.8 million in the prior quarter.
  • Across five years, Tax Provisions topped out at $63.3 million in Q1 2025 and bottomed at -$38.6 million in Q2 2023.
  • Average Tax Provisions over 5 years is -$263705.9, with a median of $488000.0 recorded in 2021.
  • The widest YoY moves for Tax Provisions: up 1344.25% in 2022, down 49602.78% in 2022.
  • A 5-year view of Tax Provisions shows it stood at -$904000.0 in 2021, then soared by 1344.25% to $11.2 million in 2022, then tumbled by 111.19% to -$1.3 million in 2023, then plummeted by 2188.56% to -$28.8 million in 2024, then soared by 319.57% to $63.3 million in 2025.
  • Per Business Quant database, its latest 3 readings for Tax Provisions were $63.3 million in Q1 2025, -$28.8 million in Q4 2024, and $8.7 million in Q3 2024.